|
|
||||||||||||||||
![]() |
|
|||||||||||||||
|
KEY ALLIANCES A major challenge in the drug discovery field is the appropriate and timely usage of key technologies, methodologies, and cutting-edge tools to qualitatively and quantitatively provide the best benchmark level analysis available. However, internalization of the literally hundreds of possible analytical disciplines can be cost prohibitive not only to the company offering the services but to the client as well who must encumber the cost that is passed along for carrying such a large and inefficient internal service structure. In order to achieve a best of both world scenario, Xtal, co-founded the Apelles Partners of companies as well as its important “Associate” level service providers to create a seamless and proprietary gateway to achieving a true 360 degree analysis of our client’s candidate molecule. A process so thorough and efficient, that we truly believe it to be unrivaled in its ability to deliver critical and in-depth data that others simply cannot provide.
Each company imparts it own in-depth domain expertise in a pointed and exacting way as needed and ordered by the Xtal team of seasoned scientists. Each of the groups mentioned above are constantly vetted for relevance and effectiveness. As new technologies, methods, and tools become available, Xtal, constantly monitors the landscape to consistently offer the best of what is available.
Thus the advantage of “one stop shopping” and “360 degree of evaluation” truly can be realized. |
|
| © Copyright 2012 XTAL BioStructures. Site map |